Serum Calprotectin Discriminates Subclinical Disease Activity from Ultrasound-Defined Remission in Patients with Rheumatoid Arthritis in Clinical Remission

about

Relationship between serum calprotectin (S100A8/9) and clinical, laboratory and ultrasound parameters of disease activity in rheumatoid arthritis: A large cohort study.Calprotectin levels in rheumatoid arthritis and their correlation with disease activity: a meta-analysis.

P2860

Q41497288-7980AE99-E708-4123-B366-D0E7AFF38120 Q51046090-518BE4D8-2BCA-4096-8FAF-71F66ECC6A4D

P2860

Serum Calprotectin Discriminates Subclinical Disease Activity from Ultrasound-Defined Remission in Patients with Rheumatoid Arthritis in Clinical Remission

Item

http://www.wikidata.org/entity/Q36188496

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

2016年论文

@zh

2016年论文

@zh-cn

name

Serum Calprotectin Discriminat ...... rthritis in Clinical Remission

@ast

Serum Calprotectin Discriminat ...... rthritis in Clinical Remission

@en

type

Item

label

Serum Calprotectin Discriminat ...... rthritis in Clinical Remission

@ast

Serum Calprotectin Discriminat ...... rthritis in Clinical Remission

@en

prefLabel

Serum Calprotectin Discriminat ...... rthritis in Clinical Remission

@ast

Serum Calprotectin Discriminat ...... rthritis in Clinical Remission

@en

P1476

Serum Calprotectin Discriminat ...... rthritis in Clinical Remission

@en

P2093

Hana Hulejova

http://www.w3.org/2001/XMLSchema#string

P2860

Two calcium-binding proteins in infiltrate macrophages of rheumatoid arthritis

Acute phase reactants add little to composite disease activity indices for rheumatoid arthritis: validation of a clinical activity score.

Early rheumatoid arthritis: time to aim for remission?

Therapeutic effect of the combination of etanercept and methotrexate compared with each treatment alone in patients with rheumatoid arthritis: double-blind randomised controlled trial.

2010 rheumatoid arthritis classification criteria: an American College of Rheumatology/European League Against Rheumatism collaborative initiative.

Modified disease activity scores that include twenty-eight-joint counts. Development and validation in a prospective longitudinal study of patients with rheumatoid arthritis.

Proinflammatory S100 proteins in arthritis and autoimmune disease.

Treating rheumatoid arthritis to target: recommendations of an international task force.

Assessment of inflammatory activity in rheumatoid arthritis: a comparative study of clinical evaluation with grey scale and power Doppler ultrasonography.

Decreases in serum levels of S100A8/9 (calprotectin) correlate with improvements in total swollen joint count in patients with recent-onset rheumatoid arthritis.

P304

e0165498

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1371/JOURNAL.PONE.0165498

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

P577

2016-11-10T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27832086

http://www.w3.org/2001/XMLSchema#string

P932

5104448

http://www.w3.org/2001/XMLSchema#string

Serum Calprotectin Discriminates Subclinical Disease Activity from Ultrasound-Defined Remission in Patients with Rheumatoid Arthritis in Clinical Remission

about

P2860

P2860

Serum Calprotectin Discriminates Subclinical Disease Activity from Ultrasound-Defined Remission in Patients with Rheumatoid Arthritis in Clinical Remission

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P50

P577

P698

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P50

P577

P698

P932